Cargando…

Identification of potential biomarkers and candidate small molecule drugs in glioblastoma

BACKGROUND AND AIMS: Glioblastoma (GBM) is a common and aggressive primary brain tumor, and the prognosis for GBM patients remains poor. This study aimed to identify the key genes associated with the development of GBM and provide new diagnostic and therapies for GBM. METHODS: Three microarray datas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Wei-cheng, Xie, Hui, Yuan, Ce, Li, Jin-jiang, Li, Zhao-yang, Wu, An-hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455906/ https://www.ncbi.nlm.nih.gov/pubmed/32874133 http://dx.doi.org/10.1186/s12935-020-01515-1

Ejemplares similares

Analyzing the lncRNA, miRNA, and mRNA-associated ceRNA networks to reveal potential prognostic biomarkers for glioblastoma multiforme
por: Zhu, Xiaolong, et al.
Publicado: (2020)

MYCN and MAX alterations in Wilms tumor and identification of novel N-MYC interaction partners as biomarker candidates
por: Jiménez Martín, Ovidio, et al.
Publicado: (2021)

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

Bioinformatics combined with quantitative proteomics analyses and identification of potential biomarkers in cholangiocarcinoma
por: Da, Zijian, et al.
Publicado: (2020)

Identification of novel biomarkers and candidate small-molecule drugs in cutaneous melanoma by comprehensive gene microarrays analysis
por: Ma, Jilei, et al.
Publicado: (2021)

Identification of drug repurposing candidates based on a miRNA-mediated drug and pathway network for cardiac hypertrophy and acute myocardial infarction
por: Sun, Jiantao, et al.
Publicado: (2018)

Identification of genes and pathways potentially related to PHF20 by gene expression profile analysis of glioblastoma U87 cell line
por: Liu, Tianlong, et al.
Publicado: (2017)

Construction of circRNA-miRNA-mRNA network and identification of novel potential biomarkers for non-small cell lung cancer
por: Yang, Jia, et al.
Publicado: (2021)

Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments
por: Gao, Lingling, et al.
Publicado: (2020)

Antitumor effects of the small molecule DMAMCL in neuroblastoma via suppressing aerobic glycolysis and targeting PFKL
por: Zhang, Simeng, et al.
Publicado: (2021)

The structure of blood–tumor barrier and distribution of chemotherapeutic drugs in non-small cell lung cancer brain metastases
por: Ye, Ling-yun, et al.
Publicado: (2021)

Identification of key candidate genes and molecular pathways in white fat browning: an anti-obesity drug discovery based on computational biology
por: Pan, Yuyan, et al.
Publicado: (2019)

Bioinformatics analysis of high-throughput data to validate potential novel biomarkers and small molecule drugs for glioblastoma multiforme
por: Qi, Fuwei, et al.
Publicado: (2020)

VWCE as a potential biomarker associated with immune infiltrates in breast cancer
por: Huo, Qin, et al.
Publicado: (2021)

Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma
por: Tian, Guocai, et al.
Publicado: (2021)

Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma
por: Lee, Chin-Cheng, et al.
Publicado: (2013)

A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer
por: Liu, Lei, et al.
Publicado: (2021)

H/ACA box small nucleolar RNA 7B acts as an oncogene and a potential prognostic biomarker in breast cancer
por: Sun, Yihan, et al.
Publicado: (2019)

Identification of key serum biomarkers for the diagnosis and metastatic prediction of osteosarcoma by analysis of immune cell infiltration
por: Chen, Zhihao, et al.
Publicado: (2022)

Time course analysis based on gene expression profile and identification of target molecules for colorectal cancer
por: Chen, Guoting, et al.
Publicado: (2016)

Targeted exome sequencing identifies mutational landscape in a cohort of 1500 Chinese patients with non-small cell lung carcinoma (NSCLC)
por: Zhou, Ya-jun, et al.
Publicado: (2021)

NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
por: Tao, Wenjie, et al.
Publicado: (2021)

Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma
por: Yu, Kai, et al.
Publicado: (2021)

Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis
por: Wu, Qiong, et al.
Publicado: (2019)

Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
por: Chen, Yuan, et al.
Publicado: (2021)

Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma
por: Zhao, Zijin, et al.
Publicado: (2021)

Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
por: Liu, Erheng, et al.
Publicado: (2023)

Identification of SNP barcode biomarkers for genes associated with facial emotion perception using particle swarm optimization algorithm
por: Chuang, Li-Yeh, et al.
Publicado: (2014)

Identification of novel key genes and potential candidate small molecule drugs in diabetic kidney disease using comprehensive bioinformatics analysis
por: Li, Bin, et al.
Publicado: (2022)

FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer
por: Xie, Qin, et al.
Publicado: (2020)

YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022)

Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis
por: Qiu, Hui-Zhu, et al.
Publicado: (2020)

Cyclobutanes in Small‐Molecule Drug Candidates
por: van der Kolk, Marnix R., et al.
Publicado: (2022)

Identification of candidate genes or microRNAs associated with the lymph node metastasis of SCLC
por: Wang, Zhonghao, et al.
Publicado: (2018)

Gene Expression Profiling of Glioblastoma to Recognize Potential Biomarker Candidates
por: Li, Qiang, et al.
Publicado: (2022)

Identification of potential plasma biomarkers in early-stage nasopharyngeal carcinoma-derived exosomes based on RNA sequencing
por: Zheng, Wei, et al.
Publicado: (2021)

Identification of novel biomarkers and candidate small molecule drugs in rheumatoid arthritis and osteoarthritis based on bioinformatics analysis of high‐throughput data
por: Zuo, Bin, et al.
Publicado: (2020)

CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment
por: Sun, Jiaxing, et al.
Publicado: (2020)

Topoisomerase IIβ mediates the resistance of glioblastoma stem cells to replication stress-inducing drugs
por: Kenig, Saša, et al.
Publicado: (2016)

Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics
por: Wang, Dongjiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e96fee1f835mg4jrcsl9nnari3